XML 99 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Reporting (Tables)
12 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Schedule of revenue by product source
   For Years ended September 30, 
   2022   2021   2020 
Sales of TCMD products manufactured by the Company  $23,988,177   $29,559,286   $18,374,751 
Sales of third-party products   16,154,974    18,422,745    12,329,209 
Total revenue  $40,143,151   $47,982,031   $30,703,960 

  

Schedule of total revenues by product categories
   For Years ended September 30, 
   2022   2021   2020 
Sales of TCMD products:            
Medicinal liquor products   1,095,336    1,951,679    1,616,080 
Other chronic condition treatment products   19,140,419    22,978,001    14,059,403 
Cold and flu medicines   3,752,422    4,629,606    2,699,268 
Sub-total of TCMD products sales   23,988,177    29,559,286    18,374,751 
                
Sales of third-party products               
Biochemical drugs   13,730,424    16,082,546    10,325,411 
Traditional Chinese medicine pieces   30,202    20,705    47,097 
Medical instruments   2,394,348    2,318,536    1,950,238 
Dietary supplements   -    958    6,463 
Subtotal of third-party products sales   16,154,974    18,422,745    12,329,209 
                
Total revenue  $40,143,151   $47,982,031   $30,703,960